Toward optimal set of single nucleotide polymorphism investigation before IVF

References

• Facchinetti F, Marozio L, Grandone E, et al. Thrombophilic mutations are a main risk factor for placental abruption. Haematologica 2003;88:785–8
   PubMed Web of Science ®Google Scholar
• Coulam CB, Jeyendran RS. Thrombophilic gene polymorphisms are risk factors for unexplained infertility. Fertil Steril 2009;91(4 Suppl):1516–17
   PubMed Web of Science ®Google Scholar
• Coulam CB, Jeyendran RS, Fishel LA, Roussev R. Multiple thrombophilic gene mutations rather than specific gene mutations are risk factors for recurrent miscarriage. Am J Reprod Immunol 2006;55:360–8
   PubMed Web of Science ®Google Scholar
• Yenicesu GI, Cetin M, Ozdemir O, et al. A prospective case-control study analyzes 12 thrombophilic gene mutations in Turkish couples with recurrent pregnancy loss. Am J Reprod Immunol 2010;63:126–36
   PubMed Web of Science ®Google Scholar
• Torabi R, Zarei S, Zeraati H, et al. Combination of thrombophilic gene polymorphisms as a cause of increased the risk of recurrent pregnancy loss. J Reprod Infertil 2012;13:89–94
   PubMedGoogle Scholar
• Coulam CB, Wallis D, Weinstein J, et al. Comparison of thrombophilic gene mutations among patients experiencing recurrent miscarriage and deep vein thrombosis. Am J Reprod Immunol 2008;60:426–31
   PubMed Web of Science ®Google Scholar
• Fábregues F, Tàssies D, Reverter JC, et al. Prevalence of thrombophilia in women with severe ovarian hyperstimulation syndrome and cost-effectiveness of screening. Fertil Steril 2004;81:989–95
   PubMed Web of Science ®Google Scholar
• Branch DW. The truth about inherited thrombophilias and pregnancy. Obstet Gynecol 2010;115:2–4
   PubMed Web of Science ®Google Scholar
• Prasolova MA, Shchepotina EG, Dymshits GM. Development of the high-throughput fluorescence assay detecting SNPs in hemostasis and folate metabolism genes for clinical use. Mol Gen Mikrobiol Virusol 2013;34–40
   PubMedGoogle Scholar
• Uvarova MA, Ivanov AV, Dedul AG, et al. The effect of single nucleotide genetic polymorphisms of folic acid cycle on the female reproductive system disorders. Gynecol Endocrinol 2015;31:34–8
   Web of Science ®Google Scholar
• Qublan HS, Eid SS, Ababneh HA, et al. Acquired and inherited thrombophilia: implication in recurrent IVF and embryo transfer failure. Hum Reprod 2006;21:2694–8
   PubMed Web of Science ®Google Scholar
• Goldstajn MS, Kovacevin D. The effect of trombophilia on pregnancy outcome and IVF success. Coll Antropol 2014;38:1153–61
   PubMedGoogle Scholar
• Bar-On S, Cohen A, Levin I, et al. Upper extremity deep vein thrombosis following ovarian stimulation. Harefuah 2011;150:849–51
   PubMedGoogle Scholar
• Nelson SM. Venous thrombosis during assisted reproduction: novel risk reduction strategies. Thromb Res 2013;131:S1–3
   PubMed Web of Science ®Google Scholar
• Wolf CE, Haubelt H, Pauer HU, et al. Recurrent pregnancy loss and its relation to FV Leiden, FII G20210A and polymorphisms of plasminogen activator and plasminogen activator inhibitor. Pathophysiol Haemost Thromb 2003;33:134–7
   PubMedGoogle Scholar
• Nurk E, Tell GS, Refsum H, et al. Factor V Leiden, pregnancy complications and adverse outcomes: the Hordaland Homocysteine Study. QJM 2006;99:289–98
   PubMed Web of Science ®Google Scholar
• Norrie G, Farquharson RG, Greaves M. Screening and treatment for heritable thrombophilia in pregnancy failure: inconsistencies among UK early pregnancy units. Br J Haematol 2009;144:241–4
   PubMed Web of Science ®Google Scholar
• Safdarian L, Najmi Z, Aleyasin A, et al. Recurrent IVF failure and hereditary thrombophilia. Iran J Reprod Med 2014;12:467–70
   PubMedGoogle Scholar
• Kupferminc MJ. Thrombophilia and pregnancy. Curr Pharm Des 2005;11:735–48
   PubMed Web of Science ®Google Scholar
• Dolitzky M, Inbal A, Brenner B, et al. A randomized study of thromboprophylaxis in women with unexplained consecutive recurrent miscarriages. Fertil Steril 2006;86:362
   PubMed Web of Science ®Google Scholar
• Simur A, Ozdemir S, Acar H, et al. Repeated in vitro fertilization failure and its relation with thrombophilia. Gynecol Obstet Invest 2009;67:109–12
   PubMed Web of Science ®Google Scholar
• Dulitzky M, Cohen SB, Inbal A, et al. Increased prevalence of thrombophilia among women with severe ovarian hyperstimulation syndrome. Fertil Steril 2002;77:463–7
   PubMed Web of Science ®Google Scholar
• Riyazi N, Leeda M, de Vries JI, et al. Low-molecular-weight heparin combined with aspirin in pregnant women with thrombophilia and a history of preeclampsia or fetal growth restriction: a preliminary study. Eur J Obstet Gynecol Reprod Biol 1998;80:49–54
   PubMed Web of Science ®Google Scholar
• Gris JC, Mercier E, Qurcie I, et al. Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder. Blood 2004;103:3695–9
   PubMed Web of Science ®Google Scholar
• Ricci G, Bogatti P, Fischer-Tamaro L, et al. Factor V Leiden and prothrombin gene G20210A mutation and in vitro fertilization: prospective cohort study. Hum Reprod 2011;26:3068–77
   PubMed Web of Science ®Google Scholar
• Göpel W, Ludwig M, Junge AK, et al. Selection pressure for the factor-V-Leiden mutation and embryo implantation. Lancet 2001;358:1238–9
   PubMed Web of Science ®Google Scholar
• Khosravi F, Zarei S, Ahmadvand N, et al. Association between plasminogen activator inhibitor 1 gene mutation and different subgroups of recurrent miscarriage and implantation failure. J Assist Reprod Genet 2014;31:121–4
   PubMed Web of Science ®Google Scholar
• Buchholz T, Lohse P, Rogenhofer N, et al. Polymorphisms in the ACE and PAI-1 genes are associated with recurrent spontaneous miscarriages. Hum Reprod 2003;18:2473–7
   PubMed Web of Science ®Google Scholar
• Dossenbach-Glaninger A, van Trotsenburg M, Dossenbach M, et al. Plasminogen activator inhibitor 1 4G/5G polymorphism and coagulation factor XIII Val34Leu polymorphism: impaired fibrinolysis and early pregnancy loss. Clin Chem 2003;49:1081–6
   PubMed Web of Science ®Google Scholar
• Idali F, Zareii S, Mohammad-Zadeh A, et al. Plasminogen activator inhibitor 1 and methylenetetrahydrofolate reductase gene mutations in iranian women with polycystic ovary syndrome. Am J Reprod Immunol 2012;68:400–7
   PubMed Web of Science ®Google Scholar
• Xuejiao L, Yukun L, Rui Z, et al. Meta-analysis of the association between plasminogen activator inhibitor-1 4G/5G polymorphism and recurrent pregnancy loss. Med Sci Monit 2015;21:1051–6
   PubMed Web of Science ®Google Scholar
• di Castelnuovo A, de Gaetano G, Benedetta Donati M, Iacoviello L. Platelet glycoprotein IIb/IIIa polymorphism and coronary artery disease: implications for clinical practice. Am J Pharmacogenomics 2005;5:93–9
   PubMedGoogle Scholar
• Zotova TIu, Frolov VA, Zotov AK, et al. Analysis of the state of coronary arteries in patients with acute coronary syndrome in dependence on the integrin (1-3 gene polymorphism). Kardiologiia 2014;54:10–13
   PubMed Web of Science ®Google Scholar
• Goncharova IA, Babushkina NP, Minashkina LI, et al. Prevalence of alleles of polymorphic variants Leu33Pro and Leu66Arg gene ITGB3 among inhabitants of Siberia. Genetika 2013;49:1008–12
   PubMedGoogle Scholar
• Germeyer A, Savaris RF, Jauckus J, Lessey B. Endometrial beta3 Integrin profile reflects endometrial receptivity defects in women with unexplained recurrent pregnancy loss. Reprod Biol Endocrinol 2014;12:53
   PubMed Web of Science ®Google Scholar
• Hooft van’t FM, von Bahr SJ, Silveira A, et al. Two common, functional polymorphisms in the promoter region of the beta-fibrinogen gene contribute to regulation of plasma fibrinogen concentration. Arterioscler Thromb Vasc Biol 1999;19:3063–70
   PubMed Web of Science ®Google Scholar
• Martinez C, Anttin AI, Corral J, et al. Genotype-phenotype relationship for six common polymorphisms in genes affecting platelet function from 286 healthy subjects and 160 patients with mucocutaneous bleeding of unknown cause. Br J Haematol 2009;146:95–103
   PubMed Web of Science ®Google Scholar
• di Paola J, Jugessur A, Goldman T, et al. Platelet glycoprotein I(b)alpha and integrin alpha2 beta1 polymorphisms: gene frequencies and linkage disequilibrium in a population diversity panel. J Thromb Haemost 2005;3:1511–21
   PubMed Web of Science ®Google Scholar
• Moshfegh K, Wuillemin WA, Redondo M, et al. Association of two silent polymorphisms of platelet glycoprotein Ia/IIa receptor with risk of myocardial infarction: a case-control study. Lancet 1999;353:351–4
   PubMed Web of Science ®Google Scholar
• Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, et al. 807 C/T polymorphism of the glycoprotein Ia gene and pharmacogenetic modulation of platelet response to dual antiplatelet treatment. Blood Coagul Fibrinolysis 2004;15:427–33
   PubMed Web of Science ®Google Scholar
• Kunicki TJ, Williams SA, Salomon DR, et al. Genetics of platelet reactivity in normal, healthy individuals. J Thromb Haemost 2009;7:2116–22
   PubMed Web of Science ®Google Scholar
• Ji H, Long V, Briody V, Chien EK. Progesterone modulates integrin {alpha}2 (ITGA2) and {alpha}11 (ITGA11) in the pregnant cervix. Reprod Sci 2011;18:156–63
   PubMed Web of Science ®Google Scholar
• Li WX, Dai SX, Zheng JJ, et al. Homocysteine metabolism gene polymorphisms (MTHFR C677T, MTHFR A1298C, MTR A2756G and MTRR A66G) jointly elevate the risk of folate deficiency. Nutrients 2015;7:6670–87
   PubMed Web of Science ®Google Scholar
• Seremak-Mrozikiewicz A, Bogacz A, Bartkowiak-Wieczorek J, et al. The importance of MTHFR, MTR, MTRR and CSE expression levels in Caucasian women with preeclampsia. Eur J Obstet Gynecol Reprod Biol 2015;188:113–17
   PubMed Web of Science ®Google Scholar
• Martínez-Frías ML, Pérez B, Desviat LR, et al. Maternal polymorphisms 677C-T and 1298A-C of MTHFR, and 66A-G MTRR genes: is there any relationship between polymorphisms of the folate pathway, maternal homocysteine levels, and the risk for having a child with Down syndrome? Am J Med Genet A 2006;140:987–97
   PubMed Web of Science ®Google Scholar
• Holmes MV, Newcombe P, Hubacek JA, et al. Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomized trials. Lancet 2011;378:584–94
   PubMed Web of Science ®Google Scholar
• Miller AL. The methionine-homocysteine cycle and its effects on cognitive diseases. Altern Med Rev 2003;8:7–19
   PubMedGoogle Scholar
• Chango A, Emery-Fillon N, de Courcy GP, et al. A polymorphism (80G->A) in the reduced folate carrier gene and its associations with folate status and homocysteinemia. Mol Genet Metab 2000;70:310–15
   PubMed Web of Science ®Google Scholar
• Varela-Moreiras G. Nutritional regulation of homocysteine: effects of drugs. Biomed Pharmacother 2001;55:448–53
   PubMed Web of Science ®Google Scholar
• Chitayat D, Matsui D, Amitai Y, et al. Folic acid supplementation for pregnant women and those planning pregnancy – 2015 update. J Clin Pharmacol 2016;56:170–5
   PubMed Web of Science ®Google Scholar
• Khaire AA, Kale AA, Joshi SR. Maternal omega-3 fatty acids and micronutrients modulate fetal lipid metabolism: a review. Prostaglandins Leukot Essent Fatty Acids 2015;98:49–55
   PubMed Web of Science ®Google Scholar
• Charita B, Padma G, Sushma P, et al. Estimation of risk and interaction of single nucleotide polymorphisms at angiotensinogen locus causing susceptibility to essential hypertension: a case control study. J Renin Angiotensin Aldosterone Syst 2012;13:461–71
   PubMed Web of Science ®Google Scholar
• Lin R, Lei Y, Yuan Z, et al. Angiotensinogen gene M235T and T174M polymorphisms and susceptibility of pre-eclampsia: a meta-analysis. Ann Hum Genet 2012;76:377–86
   PubMed Web of Science ®Google Scholar
• Mohana VU, Swapna N, Surender RS, et al. Gender-related association of AGT gene variants (M235T and T174M) with essential hypertension-a case-control study. Clin Exp Hypertens 2012;34:38–44
   PubMed Web of Science ®Google Scholar
• Rahimi Z, Rahimi Z, Mozafari H, Parsian A. Preeclampsia and angiotensin converting enzyme (ACE) I/D and angiotensin II type-1 receptor (AT1R) A1166C polymorphisms: association with ACE I/D polymorphism. J Renin Angiotensin Aldosterone Syst 2013;14:174–80
   PubMed Web of Science ®Google Scholar
• Gong FF, Hu CY, Lu SS, et al. Associations of angiotensin-converting enzyme insertion/deletion, angiotensin II receptor A1166C, and endothelial nitric oxide synthase 4b/a gene polymorphisms with pregnancy hypertensive disorders: a meta-analysis. J Clin Hypertens (Greenwich) 2015;17:954–62
   PubMed Web of Science ®Google Scholar
• Zhao L, Dewan AT, Bracken MB. Association of maternal AGTR1 polymorphisms and preeclampsia: a systematic review and meta-analysis. J Matern Fetal Neonatal Med 2012;25:2676–80
   PubMed Web of Science ®Google Scholar
• Pringle KG, Tadros MA, Callister RJ, Lumbers ER. The expression and localization of the human placental prorenin/renin-angiotensin system throughout pregnancy: roles in trophoblast invasion and angiogenesis? Placenta 2011;32:956–62
   PubMed Web of Science ®Google Scholar
• Tower CL, Lui S, Charlesworth NR, et al. Differential expression of angiotensin II type 1 and type 2 receptors at the maternal-fetal interface: potential roles in early placental development. Reproduction 2010;140:931–42
   PubMed Web of Science ®Google Scholar
• Ezra Y, Simon A, Yaron A, et al. Angiotensin-I-converting enzyme and its correlation with human follicular fluid steroids. Eur J Obstet Gynecol Reprod Biol 1992;44:71–5
   PubMed Web of Science ®Google Scholar
• Su MT, Lin SH, Chen YC, Kuo PL. Genetic association studies of ACE and PAI-1 genes in women with recurrent pregnancy loss: a systematic review and meta-analysis. Thromb Haemost 2013;109:8–15
   PubMed Web of Science ®Google Scholar
• Yang C, Fangfang W, Jie L, et al. Angiotensin-converting enzyme insertion/deletion (I/D) polymorphisms and recurrent pregnancy loss: a meta-analysis. J Assist Reprod Genet 2012;29:1167–73
   PubMed Web of Science ®Google Scholar
• Martinez-Calatrava M-J, Gonzalez-Sanchez J-L, Martinez-Larrad M-T, et al. Common haplotypes of the C-reactive protein gene and circulating leptin levels influence the interindividual variability in serum C-reactive protein levels. Thromb Haemost 2007;98:1088–95
   PubMed Web of Science ®Google Scholar
• Shen J, Arnett DK, Parnell LD, et al. Association of common C-reactive protein (CRP) gene polymorphisms with baseline plasma CRP levels and fenofibrate response: the GOLDN study. Diabetes Care 2008;31:910–15
   PubMed Web of Science ®Google Scholar
• Pai JK, Mukamal KJ, Rexrode KM, Rimm EB. C-reactive protein (CRP) gene polymorphisms, crp levels, and risk of incident coronary heart disease in two nested case-control studies. PLoS One 2008;3:e1395
   PubMed Web of Science ®Google Scholar
• Kolz M, Koenig W, M enig M, et al. DNA variants, plasma levels and variability of C-reactive protein in myocardial infarction survivors: results from the AIRGENE study. Eur Heart J 2008;29:1250–8
   PubMed Web of Science ®Google Scholar
• Teran E, Escudero C, Calle A. C-reactive protein during normal pregnancy and preeclampsia. Int J Gynecol Obstet 2005;89:299–300
   PubMed Web of Science ®Google Scholar
• Girelli D, Russo C, Ferraresi P, et al. Polymorphisms in the factor VII gene and the risk of myocardial infarction in patients with coronary artery disease. N Engl J Med 2000;343:774–80
   PubMed Web of Science ®Google Scholar
• di Castelnuovo A, D’Orazio A, Amore C, et al. Genetic modulation of coagulation factor VII plasma levels: contribution of different polymorphisms and gender-related effects. Thromb Haemost 1998;80:592–7
   PubMed Web of Science ®Google Scholar
• Wells PS, Anderson JL, Rodger MA, et al. The factor XIII Val34Leu polymorphism: is it protective against idiopathic venous thromboembolism? Blood Coagul Fibrinolysis 2006;17:533–8
   PubMed Web of Science ®Google Scholar
• Wells PS, Anderson JL, Scarvelis DK, et al. Factor XIII Val34Leu variant is protective against venous thromboembolism: a HuGE review and meta-analysis. Am J Epidemiol 2006;164:101–9
   PubMed Web of Science ®Google Scholar
• Fontana P, Dupont A, Gandrille S, et al. Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects. Circulation 2003;108:989–95
   PubMed Web of Science ®Google Scholar
• Muslimova EF, Rebrova TY, Serebryakova VN, et al. Association of polymorphism of genes ACE, NOS3, ITGB3 and P2RY12 with total cholesterol and glucose in working-age women of West Siberian region. Far East Med J 2015; in press
   Google Scholar
• Vassilatis DK, Hohmann JG, Zeng H, et al. The G protein-coupled receptor repertoires of human and mouse. Proc Natl Acad Sci USA 2003;100:4903–8
   PubMed Web of Science ®Google Scholar
• Kunicki TJ, Williams SA, Nugent DJ. Genetic variants that affect platelet function. Curr Opin Hematol 2012;19:371–9
   PubMed Web of Science ®Google Scholar
• Lanza F. Bernard-Soulier syndrome (hemorrhagiparous thrombocytic dystrophy). Orphanet J Rare Dis 2006;1:46
   PubMed Web of Science ®Google Scholar
• Simsek S, Bleeker PM, van der Schoot CE, von dem Borne AE. Association of a variable number of tandem repeats (VNTR) in glycoprotein Ib alpha and HPA-2 alloantigens. Thromb Haemost 1994;72:757–61
   PubMed Web of Science ®Google Scholar
• Kobashi G, Yamada H, Ohta K, et al. Endothelial nitric oxide synthase gene (NOS3) variant and hypertension in pregnancy. Am J Med Genet 2001;103:241–4
   PubMed Web of Science ®Google Scholar
• Hillermann R, Carelse K, Gebhardt GS. The glu298asp variant of the endothelial nitric oxide synthase gene is associated with an increased risk for abruptio placentae in pre-eclampsia. J Hum Genet 2005;50:415–19
   PubMed Web of Science ®Google Scholar
• Thomas DD, Heinecke JL, Ridnour LA, et al. Signaling and stress: the redox landscape in NOS2 biology. Free Radic Biol Med 2015;87:204–25
   PubMed Web of Science ®Google Scholar
• del Carmen Terrones Saldívar M, Juárez FJ, Viramontes JL, et al. Glutathione S-transferases and esterases in placenta after normal and pre-eclamptic pregnancies. Placenta 2004;25:331–6
   PubMed Web of Science ®Google Scholar
• Tatarskyy PF, Kucherenko AM, Khazhilenko KG, et al. Study of the possible role of the polymorphism of the detoxication and coagulation system genes of pathogenesis of pregnancy loss. Biopolymers and Cell 2011;27:214–20
   Google Scholar
• Roes EM, Raijmakers MT, Roelofs HM, et al. Urinary GSTP1-1 excretion is markedly increased in normotensive pregnancy as well as in preeclampsia. J Nephrol 2005;18:405–8
   PubMed Web of Science ®Google Scholar
• Liu X, An BH, Kim MJ, et al. Human glutathione S-transferase P1-1 functions as an estrogen receptor. Biochem Biophys Res Commun 2014;452:840–4
   PubMed Web of Science ®Google Scholar
• Costa LG, Li WF, Richter RJ, et al. The role of paraoxonase (PON1) in the detoxication of organophosphates and its human polymorphism. Chem Biol Interact 1999;119–120:429–38
   PubMed Web of Science ®Google Scholar
• Mashayekhi F, Behrouzi S, Yousefi M, Salehi Z. The association of PON1 192 Q/R polymorphism and the risk of female infertility. Cell Mol Biol 2015;61:74–7
   PubMed Web of Science ®Google Scholar
• Younis A, Clower C, Nelsen D, et al. The relationship between pregnancy and oxidative stress markers on patients undergoing ovarian stimulations. Assist Reprod Genet 2012;29:1083–9
   PubMed Web of Science ®Google Scholar
• Bangerter M, G ngner C, Beneke H, et al. Pregnancy in essential thrombocythaemia: treatment and outcome of 17 pregnancies. Eur J Haematol 2000;65:165–9
   PubMed Web of Science ®Google Scholar
• Mercier E, Lissalde-Lavigne G, Gris JC. JAK2 V617F mutation in unexplained loss of first pregnancy. N Engl J Med 2007;357:1984–5
   PubMed Web of Science ®Google Scholar
• Yoo JH, Park TS, Maeng HY, et al. JAK2 V617F/C618R mutation in a patient with polycythemia vera: a case study and review of the literature. Cancer Genet Cytogenet 2009;189:43–7
   PubMedGoogle Scholar
• Grandone E, Colaizzo D, Tiscia G, et al. Impact of common thrombophilias and JAK2 V617F on pregnancy outcomes in unselected Italian women. Thromb Haemost 2011;9:496–501
   Web of Science ®Google Scholar